SN BioScience gets FDA orphan drug tag for gastric cancer therapy
December 24, 2025 | 14:05
The designation provides incentives for developing its nano-particle drug to treat a form of stomach cancer.
Nature Medicine Publishes Innovent’s Promising Phase 1 Gastric Cancer Data
July 17, 2025 | 11:00
Early results shine a light on targeted hope for advanced adenocarcinoma patients.
Mobile Version